Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: May 4, 2020
Date Accepted: Jul 24, 2020
Date Submitted to PubMed: Aug 7, 2020

The final, peer-reviewed published version of this preprint can be found here:

Acceptability of App-Based Contact Tracing for COVID-19: Cross-Country Survey Study

Altmann S, Milsom L, Zillessen H, Blasone R, Gerdon F, Bach R, Kreuter F, Nosenzo D, Toussaert S, Abeler J

Acceptability of App-Based Contact Tracing for COVID-19: Cross-Country Survey Study

JMIR Mhealth Uhealth 2020;8(8):e19857

DOI: 10.2196/19857

PMID: 32759102

PMCID: 7458659

Acceptability of app-based contact tracing for COVID-19: Cross-country survey evidence

  • Samuel Altmann; 
  • Luke Milsom; 
  • Hannah Zillessen; 
  • Raffaele Blasone; 
  • Frederic Gerdon; 
  • Ruben Bach; 
  • Frauke Kreuter; 
  • Daniele Nosenzo; 
  • Séverine Toussaert; 
  • Johannes Abeler

ABSTRACT

Background:

The COVID-19 pandemic is the greatest public health crisis of the last 100 years. Countries have responded with various levels of lockdown to save lives and stop health systems from being overwhelmed. At the same time, lockdowns entail large socio-economic costs. One exit strategy under consideration is a mobile phone app that traces close contacts of those infected with COVID-19. Recent research has demonstrated the theoretical effectiveness of this solution in different disease settings. However, concerns have been raised about such apps because of the potential privacy implications. This could limit the acceptability of app-based contact tracing among the general population. As the effectiveness of this approach increases strongly with app take-up, it is crucial to understand public support for this intervention.

Objective:

The objective of this study is to investigate user acceptability of a contact-tracing app in five countries hit by the pandemic.

Methods:

We conducted a multi-country, large-scale (N = 5995) study to measure public support for digital contact tracing of COVID-19 infections. We ran anonymous online surveys in France, Germany, Italy, the UK and the US. We measured intentions to use a contact-tracing app across different installation regimes (voluntary installation vs. automatic installation by mobile phone providers), and studied how these intentions vary across individuals and countries.

Results:

We found strong support for the app under both regimes, in all countries, across all sub-groups of the population, and irrespective of regional-level COVID-19 mortality rates. We investigated the main factors that may hinder or facilitate take-up and found that concerns about cyber security and privacy, together with lack of trust in government, are the main barriers to adoption.

Conclusions:

Epidemiological evidence shows that app-based contact-tracing can suppress the spread of COVID-19 if a high enough proportion of the population uses the app and that it can still reduce the number of infections if take-up is moderate. Our findings show that the willingness to install the app is very high. The available evidence suggests that app-based contact tracing may be a viable approach to control the diffusion of COVID-19.


 Citation

Please cite as:

Altmann S, Milsom L, Zillessen H, Blasone R, Gerdon F, Bach R, Kreuter F, Nosenzo D, Toussaert S, Abeler J

Acceptability of App-Based Contact Tracing for COVID-19: Cross-Country Survey Study

JMIR Mhealth Uhealth 2020;8(8):e19857

DOI: 10.2196/19857

PMID: 32759102

PMCID: 7458659

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.

Advertisement